HEALWELL AI To Present At The 2025 Cantech Investment Conference In Toronto
Presentation Time: 2:00 PM EST in Track 1
Date: Thursday, October 9, 2025
Location: Arcadian Loft, 8th floor, 401 Bay Street, Toronto, ON
Contact: ... to register
More info:
Dr. Alexander Dobranowski will also be speaking on the Lunch Keynote Panel: "AI Investment Opportunities", where he will share HEALWELL's capital allocation story and highlight the Company's growth over the past two years.
Dr. Alexander Dobranowski, President of HEALWELL, commented, "We are pleased to be presenting at the Cantech Investment Conference again this year. Cantech brings together Canada's leading investors, analysts, and capital markets professionals. The conference provides an excellent opportunity to share HEALWELL's vision for advancing preventative healthcare through AI and to further engage with the investment community."
James Lee
Chief Executive Officer
HEALWELL AI Inc.
About The Cantech Investment Conference
The Cantech Investment Conference, recognized as Canada's foremost technology and diversified industries investment event, provides emerging companies with the unique opportunity to showcase their innovations and growth strategies, and participate in individual 1-on-1 meetings with potential investors and capital markets professionals. The conference serves as a hub for networking, knowledge exchange, and investment opportunities, while also featuring panel discussions with industry experts to offer insights into current trends, challenges, and opportunities. For fifteen years, Cantech Media, the parent company of Cantech Letter, has been committed to the innovation sectors in the Canadian public markets. Cantech Letter gathers research from Canada's leading investment banks to provide individual investors with timely, expert voices in the space.
About HEALWELL AI
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit .

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Utila Triples Valuation In Six Months As Stablecoin Infrastructure Demand Triggers $22M Extension Round
- Cregis Joins TOKEN2049 Singapore 2025
- Jpmorgan Product Head Joins GSR Trading MD To Build Institutional Staking Markets
- Stratx Launches Compliance-Aware Routing Protocol For Stablecoins, Rwas, And Cross-Border Settlement
- “Farewell To Westphalia” Explores Blockchain As A Model For Post-Nation-State Governance
- DOLLUM Expands Wallet Opportunities, Introducing New Security Features Following The DOL Token Sale
Comments
No comment